Watch the expert talk with Simone Biscaglia, MD, from Ferrara University Hospital and gain deeper insights into the FIRE trial. Hear the main study's results and learn about the study objective and design of the CLASSY FIRE sub-study investigating the potential of ClearStent to help optimize PCI for improved post-PCI outcomes.
Expert talk: FIRE trial study Functional versus culprit-only revascularization in elderly patients with myocardial infarction and multivessel disease
For more insights into clinical cases, papers, and studies and watch different expert talks and webinars by specialities in the field register here.
Did this information help you?
The statements by Siemens Healthineers customers described herein are based on results that were achieved in the customer’s unique setting. Because there is no “typical” hospital or laboratory and many variables exist (e.g. hospital size, samples mix, case mix, level of IT and/or automation adoption) there can be no guarantee that other customers will achieve the same results.
The opinions expressed in this clinical focus dialogue are solely those of the featured physicians and may not reflect the views of Siemens Healthineers.
The information presented in the clinical focus dialogue is for illustration only and is not intended to be relied upon by the reader for instruction as to the practice of medicine.
Simone Biscaglia, MD is employed by an institution that receives financial support from Siemens Healthineers for collaborations.
The product/features (mentioned herein) are not commercially available in all countries. Their future availability cannot be guaranteed.
The opinions expressed in this clinical focus dialogue are solely those of the featured physicians and may not reflect the views of Siemens Healthineers.
The information presented in the clinical focus dialogue is for illustration only and is not intended to be relied upon by the reader for instruction as to the practice of medicine.
Simone Biscaglia, MD is employed by an institution that receives financial support from Siemens Healthineers for collaborations.
The product/features (mentioned herein) are not commercially available in all countries. Their future availability cannot be guaranteed.